Lexpos News

NHS England has published details of two training opportunities that may be of interest to community pharmacy owners and their teams. The first is the 2026 offer of independent prescribing training for pharmacists, with funding for the courses available at universities across England, with multiple start dates up to March 2027. Find out more information, [...]

The post NHS England training opportunities: IP training and Pharmacy Technician Apprenticeship Programme appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has today (24/04/2026) confirmed the following list of price concessions for April 2026: Please note: Community Pharmacy England has submitted price concession applications for a number of other medicines affected by pricing issues this month. We will issue further updates as soon as we hear back from the [...]

The post April 2026 Price Concessions 3rd Update appeared first on Community Pharmacy England.

With Early May Bank Holiday (4 May 2026) occurring in the first five days of the FP34C submission window, pharmacy owners will have an extra day, until the end of 6 May 2026, to submit their April FP34Cs using the Manage Your Service (MYS) portal and to dispatch their prescription bundle to the relevant pricing division [...]

The post Extended FP34C submission deadline for prescriptions dispensed in April 2026 appeared first on Community Pharmacy England.

A report by Edge Health, sponsored by Sandoz, has examined the growing pressures on community pharmacies and the long-term sustainability of the sector. The report says that community pharmacies are facing growing operational and financial pressures, highlighting that: Increasing time is being spent by pharmacies comparing medicine prices and sourcing stock from multiple wholesalers for [...]

The post Our response to Edge Health’s report on the future of community pharmacy appeared first on Community Pharmacy England.

MHRA Class 3 Medicines Recall: Napralief 250mg Gastro-Resistant Tablets (Omega Pharma Ltd) Drug Alert Number: EL(25)A/21 Date issued: 23 April 2026 Omega Pharma Ltd is recalling specific batches of Napralief 250mg Gastro-Resistant Tablets due to missing text in Section 2 and Section 3 of the Patient Information Leaflet (PIL) and on the Carton in packs of [...]

The post MHRA Class 3 Medicines Recall: Napralief 250mg Gastro-Resistant Tablets (Omega Pharma Ltd) appeared first on Community Pharmacy England.